QUOTED. 19 February 2020. Stephen Hahn.
The US FDA has abandoned all near-term plans to inspect Chinese manufacturing facilities in the wake of the coronavirus crisis. See what agency head Stephen Hahn said about it here.
“The FDA is not currently conducting inspections in China due to the State Department warning advising against travel to China.” – Stephen Hahn, commissioner, US FDA
- Find out more: Coronavirus: All FDA Inspections Of Chinese Manufacturing Facilities Come To Screeching Halt
Click here for a free trial of Medtech Insight